Fintel on MSN11d
Raymond James Initiates Coverage of Erasca (ERAS) with Outperform Recommendation
Fintel reports that on March 26, 2025, Raymond James initiated coverage of Erasca (NasdaqGS:ERAS) with a Outperform ...
Yahoo Finance3d
Erasca, Inc. (ERAS)
Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 Erasca will also present potential first-in-class examples of direct SMP ...
Morgan Stanley Keeps Their Buy Rating on Erasca (ERAS)
In a report released today, Sean Laaman from Morgan Stanley maintained a Buy rating on Erasca (ERAS – Research Report), with a price target of ...
Erasca (ERAS) Gets a Buy from J.P. Morgan
In a report released on March 28, Anupam Rama from J.P. Morgan maintained a Buy rating on Erasca (ERAS – Research Report). The company’s shares ...
Yahoo Finance1mon
Erasca, Inc. (ERAS)
SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies ...